CIBC Private Wealth Group
ARLZ

CIBC Private Wealth Group’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History

CIBC Private Wealth Group’s Portfolio ARLZ Stock Details ARLZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-3,362
Closed -$1K – 2022
2018
Q2 		$1K Hold
3,362
– – ﹤0.01% 1940
2018
Q1 		$5K Hold
3,362
– – ﹤0.01% 1685
2017
Q4 		$5K Buy
+3,362
New +$5.52K ﹤0.01% 1710

Other funds holding ARLZ

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

CIBC Private Wealth Group's ARLZ Position: Q3 2018 in Review

CIBC Private Wealth Group sold out of Aralez Pharmaceuticals Inc. (ARLZ) in Q3 2018, closing a stake of 3,362 shares — an estimated $1K sold.

CIBC Private Wealth Group first reported a position in ARLZ in Q4 2017 and held it in 3 quarters. The position peaked at $5K in Q1 2018. 4 funds tracked by Wall St. Rank hold ARLZ as of Q3 2018.

  • CIBC Private Wealth Group reported no remaining Aralez Pharmaceuticals Inc. position as of Q3 2018 after selling out during the quarter.
  • CIBC Private Wealth Group sold 3,362 Aralez Pharmaceuticals Inc. shares in Q3 2018, an estimated $1K.
  • CIBC Private Wealth Group first reported a position in Aralez Pharmaceuticals Inc. in Q4 2017 and held it in 3 quarters.
  • CIBC Private Wealth Group's Aralez Pharmaceuticals Inc. position peaked at $5K in Q1 2018.
  • 4 funds tracked by Wall St. Rank held Aralez Pharmaceuticals Inc. as of Q3 2018.

Based on CIBC Private Wealth Group's 13F filing for Q3 2018, filed 14 Nov 2018.